
|Videos|April 21, 2022
Patient Quality of Life on Lenvatinib plus Pembrolizumab Treatment for Renal Cell Carcinoma
Oncologists review quality of life data for patients with renal cell carcinoma receiving lenvatinib plus pembrolizumab combination treatments.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Removes Black Box Warning for Breast Cancer and Other Indications on HRT Products
2
What Were the Key Abstracts and Presentations at The 2026 Tandem Meetings?
3
How Tolerable is Pembrolizumab/Paclitaxel/Bevacizumab in PROC?
4
Advances in Immunotherapy for Breast Cancer
5





















































